MWM
Massachusetts Wealth Management Portfolio holdings
AUM
$177M
This Quarter Return
-0.22%
1 Year Return
+16.45%
3 Year Return
–
5 Year Return
–
10 Year Return
–
AUM
$162M
AUM Growth
+$162M
(+2.1%)
Cap. Flow
+$5.74M
Cap. Flow
% of AUM
3.54%
Top 10 Holdings %
Top 10 Hldgs %
28.82%
Holding
92
New
4
Increased
41
Reduced
32
Closed
2
Top Buys
| 1 |
Baker Hughes
BKR
|
$843K |
| 2 |
Halliburton
HAL
|
$765K |
| 3 |
Industrial Select Sector SPDR Fund
XLI
|
$658K |
| 4 |
Financial Select Sector SPDR Fund
XLF
|
$655K |
| 5 |
Technology Select Sector SPDR Fund
XLK
|
$371K |
Top Sells
| 1 |
AstraZeneca
AZN
|
$226K |
| 2 |
Allegion
ALLE
|
$221K |
| 3 |
Pfizer
PFE
|
$75.2K |
| 4 |
Boeing
BA
|
$66.4K |
| 5 |
UBS Group
UBS
|
$60.6K |
Sector Composition
| 1 | Industrials | 18.13% |
| 2 | Financials | 11.77% |
| 3 | Technology | 10.46% |
| 4 | Consumer Staples | 9.64% |
| 5 | Healthcare | 9.12% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
76
Public Service Enterprise Group
PEG
$40.8B
| $431K | 0.27% |
5,100
-150
| -3% | -$12.7K |
|
77
Biogen
BIIB
$20.5B
| $419K | 0.26% |
2,740
-135
| -5% | -$20.6K |
|
78
FedEx
FDX
$52.9B
| $374K | 0.23% |
1,330
| – | – |
|
79
Dow Inc
DOW
$17.3B
| $374K | 0.23% |
9,316
-247
| -3% | -$9.91K |
|
80
Freeport-McMoran
FCX
$64.5B
| $337K | 0.21% |
8,842
-400
| -4% | -$15.2K |
|
81
SPDR S&P Oil & Gas Exploration & Production ETF
XOP
$1.92B
| $296K | 0.18% |
+2,235
| New | +$296K |
|
82
United Parcel Service
UPS
$72.2B
| $293K | 0.18% |
2,320
-25
| -1% | -$3.15K |
|
83
iShares Biotechnology ETF
IBB
$5.69B
| $270K | 0.17% |
+2,045
| New | +$270K |
|
84
Materials Select Sector SPDR Fund
XLB
$5.49B
| $253K | 0.16% |
3,005
+315
| +12% | +$26.5K |
|
85
Broadcom
AVGO
$1.4T
| $253K | 0.16% |
+1,090
| New | +$253K |
|
86
Visa
V
$679B
| $253K | 0.16% |
799
| – | – |
|
87
Oracle
ORCL
$633B
| $242K | 0.15% |
1,450
| – | – |
|
88
UnitedHealth
UNH
$280B
| $231K | 0.14% |
457
| – | – |
|
89
Novo Nordisk
NVO
$251B
| $219K | 0.14% |
2,550
-600
| -19% | -$51.6K |
|
90
Morgan Stanley
MS
$238B
| $201K | 0.12% |
+1,602
| New | +$201K |
|
|
91
Allegion
ALLE
$14.4B
| – | – |
-1,519
| Closed | -$221K |
|
|
92
AstraZeneca
AZN
$249B
| – | – |
-2,900
| Closed | -$226K |
|